Form 4: Vita Coco CEO Martin Roper Sells Shares Under 10b5-1 Plan
SEC Form 4
Vita Coco's CEO, Martin Roper, executed multiple sales of company stock under a pre-arranged 10b5-1 trading plan, both directly and through family trusts.
Summary
- Martin Roper, CEO of Vita Coco, sold 5,000 shares of common stock on each of December 11th and 12th, 2024, at weighted average prices of $36.532 and $37.29 respectively.
- These sales were executed under a pre-arranged Rule 10b5-1 trading plan.
- Additionally, shares held in family trusts associated with Chris Roper, Peter Roper, and Thomas Roper were also sold on the same dates, with each trust selling 5,000 shares per day.
- The sales by the family trusts were also at weighted average prices, with the prices ranging from $36.34 to $36.70 on December 11th and $36.84 to $37.65 on December 12th.
- After these transactions, Martin Roper directly owns 352,152 shares and indirectly owns 309,127 shares through the Chris Roper trust, 309,025 shares through the Peter Roper trust, and 309,225 shares through the Thomas Roper trust.
- Martin Roper also holds various non-qualified stock options with different vesting schedules and exercise prices.
Sentiment
Score: 5
Explanation: The document is neutral in sentiment as it reports on routine stock sales under a pre-arranged plan. There is no indication of positive or negative news about the company's performance.
Risks
- The sales by the CEO and related trusts could be perceived negatively by the market, potentially impacting the stock price.
- The reliance on a 10b5-1 plan suggests a pre-determined strategy for selling shares, which could indicate a lack of confidence in the company's short-term prospects, although this is not necessarily the case.
Industry Context
Executive stock sales are a common occurrence, and the use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading. The impact on the stock price will depend on market sentiment and the overall performance of the company.
Comparison to Industry Standards
- The use of 10b5-1 trading plans is a common practice among executives at publicly traded companies, including those in the beverage industry such as Coca-Cola and PepsiCo.
- The size of the stock sales by Martin Roper is not unusual for a CEO, and the fact that they are spread across multiple days and family trusts is also typical.
- The vesting schedules and exercise prices of the stock options are also within the range of what is seen in executive compensation packages at comparable companies.
Stakeholder Impact
- The stock sales could potentially cause a slight decrease in the share price, impacting shareholders.
- The sales do not directly impact employees, customers, or suppliers.
Key Dates
| Date | Description |
|---|---|
| 01/11/2023 | First vesting date for one of Martin Roper's stock option grants. |
| 11/27/2022 | First vesting date for one of Martin Roper's stock option grants. |
| 03/10/2024 | First vesting date for one of Martin Roper's stock option grants. |
| 03/04/2025 | First vesting date for one of Martin Roper's stock option grants. |
| 12/11/2024 | Date of first reported stock sales by Martin Roper and related trusts. |
| 12/12/2024 | Date of second reported stock sales by Martin Roper and related trusts. |
| 12/13/2024 | Date of filing of the Form 4. |
| 09/19/2029 | Expiration date for one of Martin Roper's stock option grants. |
| 01/11/2031 | Expiration date for one of Martin Roper's stock option grants. |
| 10/21/2031 | Expiration date for one of Martin Roper's stock option grants. |
| 03/10/2033 | Expiration date for one of Martin Roper's stock option grants. |
| 03/04/2034 | Expiration date for one of Martin Roper's stock option grants. |
Keywords
Vita Coco, Martin Roper, stock sales, Rule 10b5-1, insider trading, executive compensation, family trusts, stock options
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.